10.02.2013 Views

Immunotherapy for Infectious Diseases

Immunotherapy for Infectious Diseases

Immunotherapy for Infectious Diseases

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Production of Igs and MAbs Targeting <strong>Infectious</strong> <strong>Diseases</strong> 69<br />

Fig. 5. mRNA of variable regions and corresponding polypeptides vH and vL. mRNAs of<br />

antibodies are composed of V-(D)-J regions. These are translated as vH and vL, characterized<br />

by relatively conserved FR regions and antigen-binding complementary determing regions<br />

(CDRs).<br />

Table 1<br />

Generation of Immunoglobulin Diversity by Independent Mechanisms<br />

Multiple germline V, D, and J genes<br />

Different V-J light chain and V-D-J heavy chain recombinations<br />

Recombinational inaccuracies<br />

Somatic point mutations<br />

Assorted heavy and light chains<br />

resulting antibody assortment through the combination of heavy and light chains,<br />

somatic point mutations, and recombinational accuracy. Table 1 summarizes these five<br />

mechanisms that allow the generation of a repertoire of at least 10 8 different antibodies,<br />

sufficient to recognize most antigens invading the body. Modern DNA recombination<br />

technologies learned to copy these naturally occurring principles <strong>for</strong> the design of<br />

artificial antibody molecules.<br />

IN VIVO APPLICATION OF ANTIBODIES<br />

Immunoglobulins <strong>for</strong> Therapeutic Applications<br />

Immunoglobulins in the <strong>for</strong>m of injectable polyclonal gammaglobulins, so-called<br />

intramuscular immunoglobulin (IMIG) and intravenous immunoglobulin (IVIG) preparations,<br />

have been used since 1944. In IVIG preparations, antibody oligomers must be<br />

elimimated, to avoid spontaneous complement activation. The associated side effects<br />

(adverse reactions) of the first generation of serotherapy were overcome by Cohn fractionation<br />

technology (3). IVIG is prepared from pools of serum collected from large<br />

numbers of healthy donors. Cohn-Oncley cold ethanol fractionation is based on the<br />

principle that proteins can specifically precipitate in a certain environment, according<br />

to size, charge, and other physicochemical properties. This technology is used by several<br />

manufacturers to separate the �-globulin fraction from other serum proteins. Subsequent<br />

biochemical steps downstream of the Cohn fraction are applied and may<br />

include ion exchange chromatography, ultrafiltration, enzymatic digestion, manipulation<br />

of pH, and salt concentration; these vary with the manufacturer. These procedures

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!